1. The aim of this study was to determine the effects of high (220 mmol/day) and low (40 mmol/day) salt intake for 6 days on blood pressure, leg blood flow and insulin sensitivity in 18 healthy normotensive subjects.
INTRODUCTION
Acute hyperinsulinaemia is associated with vasodilatation. Vasodilatation induced by insulin is time-and dosedependent and it occurs despite a concomitant 30 % rise in catecholamine concentrations during acute insulin administration, for example during a hyperinsulinaemiceuglycaemic clamp [1, 2] . This vasodilatation is associated with an increase in cardiac output and with a preferential reduction in peripheral vascular resistance, compared with that in systemic vascular resistance, implying a predominant effect on limb blood vessels [3] [4] [5] . Under conditions of 1-2 h of hyperinsulinaemia, glucose extraction increases over 10-fold while muscle blood flow increases approximately 20-40 % [6] . Laakso et al. [7] used sequential increases in insulin lasting up to 9-10 h and demonstrated a 2-fold increase in muscle blood flow. As insulin vasodilates it increases the supply of blood, nutrients and hormones to target tissues, perhaps promoting to a certain extent its delivery to, and action on, skeletal muscle [8] . In insulin-resistant states such as hypertension, obesity and Type II diabetes mellitus, insulin-mediated vasodilatation is attenuated [7, [9] [10] [11] [12] [13] . Baron [14, 15] has produced data indicating that insulinmediated vasodilatation may play an important role in the overall action of insulin in stimulating glucose uptake. The contribution of muscle blood flow to insulin action, however, is still widely disputed. Nuutila et al. [16] did not find any increase in insulin-mediated glucose uptake despite increasing leg blood flow with bradykinin infusions ; other groups have also found no relationship between increased muscle blood flow and insulin action using infusions of adenosine or angiotensin II [17] [18] [19] .
There have been suggestions that the reninangiotensin-aldosterone (RAA) system may influence insulin sensitivity [19] [20] [21] [22] [23] [24] . If muscle blood flow is a major determinant of insulin-mediated glucose uptake, one might expect that other situations which change haemodynamics and the RAA axis, e.g. salt-loading, will influence insulin sensitivity. Stein et al. [25] have shown that salt-loading enhances the forearm blood flow response to sodium nitroprusside but not to methacholine, implying that salt mediates increases in blood flow via an endothelium-independent pathway. Feldman et al. [26] found that the vascular\vasodilating effect of insulin was reduced during salt restriction.
The haemodynamic reponses to salt-loading are variable, but in general chronic salt-loading increases cardiac output [27] while total peripheral resistance and blood pressure responses vary [27] [28] [29] . Dietary salt intake may affect other variables associated with insulin resistance, e.g. fasting lipids and insulin [30, 31] . There have been conflicting reports on the effects of salt-loading on insulin sensitivity [30] [31] [32] [33] . It is unclear as to whether the variable responses of glucose metabolism and blood flow to saltloading are related, such that some individuals both vasodilate and increase their glucose clearance, whereas others show neither response.
We therefore studied the effects of salt-loading and the possible mechanism of any such action. We hypothesized that salt-loading suppresses the RAA axis and influences insulin sensitivity via changes in muscle blood flow.
METHODS

Subjects
Eighteen healthy volunteers (8 male, 10 female) were recruited from a GP practice register. Physical examination was normal in all subjects. Volunteers with a history of ischaemic heart disease, hypertension, peripheral vascular disease or peripheral neuropathy were excluded. All volunteers had normal renal function (serum creatinine 120 µmol\l, urinary protein 0.07 g\24 h), liver function, fasting glucose 6.0 mmol\l and lipid profile (total cholesterol 6.0 mmol\l, triacylglycerol 1.8 mmol\l). The study was approved by the Whittington Hospital Ethics Committee. The characteristics of the subjects are shown in Table 1 .
Anthropometry
Weight was measured using a digital weighing machine (Seca, Marsdens, London, U.K.) to the nearest 0.1 kg. Height was measured using a Harpenden stadiometer (Holtain Ltd, Crymych, Dyfed, U.K.). Skinfold thickness was measured on the triceps and subscapular area using a pair of callipers (Holtain Ltd) [34] . Triceps skin fold thickness was taken half way between the inferior border of the acromion process and the tip of the olecranon process, directly in line with the point of the elbow and the acromion process. Subscapular skinfold thickness was measured just below the tip of the scapula with the skinfold taken at an angle of 45m to the vertical. 
Study design (Figure 1)
Subjects were studied on three occasions : at baseline and after two periods of low salt and of high salt intake. A dietary history was taken at baseline and subjects were placed on a low salt diet (40 mmol\day) for two 6-day periods separated by 4 weeks of normal salt intake. They were then randomized to receive either placebo or slow sodium (180 mmol\day ; Ciba-Geigy, Horsham, Sussex, U.K.) in a double-blind cross-over fashion for one of the two 6-day periods. Compliance was checked by 24-h urinary sodium collection on day 5 and by tablet count. During the two study periods, investigations comprised 24-h urinary electrolytes, protein and urinary catecholamines, 24-h ambulatory blood pressure, insulin sensitivity by hyperinsulinaemic-euglycaemic clamp and venous occlusion plethysmography for limb blood flow. Measurement of 24-h ambulatory blood pressure was performed at baseline, and on day 6 of each study period, with a Takeda TM-2420 ambulatory blood pressure monitor (A&D Company Ltd, Shibuya-ku, Tokyo, Japan) at 30-min intervals during the day (07 : 00 to 23.00 h) and hourly at night (23.00 to 07.00 h). The blood pressure cuff was placed on the non-dominant arm and subjects were advised to carry out their normal daily routine and to keep a diary for the whole period. On day 5, 24-h ambulatory blood pressure was repeated and urine electrolytes were measured from a 24-h urine collection. On day 6, subjects arrived at the Clinical Investigation Unit at 08.30 h, having fasted from midnight. They were weighed and a further 24-h urine collection started for measurement of catecholamines.
Subjects rested supine for 20 min before blood sampling for renin, angiotensin II, aldosterone and insulin. Plasma volume measurement and a two-step hyperinsulinaemic-euglycaemic clamp were performed. Leg blood flows were measured at 100-120 min into each clamp dose with venous occlusion plethysmography.
Plasma volume measurement with Evans Blue [35,36]
Plasma volume was estimated by Evans Blue dilution method. Fifteen milligrams of Evans Blue dye (New World Trading, DeBary, FL, U.S.A.) was injected into the antecubital cannula after blood had been withdrawn for calibration of a spectrophotometer. The cannula was thoroughly washed through with normal saline. Blood samples were withdrawn 10 min after injection, and every 5 min thereafter for a further 20 min. The samples were allowed to clot before centrifugation and the concentration of the dye in the serum determined by comparing with known concentrations of dye made in undiluted serum from the same patient using a spectrophotometer. The theoretical concentration of dye in the plasma at the time of injection was estimated by extrapolating the exponential decay curve back to time zero. We have shown in separate studies that the dose of Evans Blue dye used to measure plasma volume did not affect our blood flow readings in the basal or insulin-stimulated state. 
Hyperinsulinaemic-euglycaemic clamp [37]
Soluble insulin (Human Actrapid, NovoNordisk, Basingstoke, Hants, U.K.) and 10 % dextrose with 20 mmol of potassium per 500 ml bag were infused into the antecubital vein at variable rates to maintain euglycaemia at fasting glucose level. Subjects were clamped at two doses of insulin infusion, i.e. 40 and 600 munit:min −" :m −# . Insulin sensitivity was calculated as the metabolic clearance rate of glucose using the mean infusion rate over 30 min (approximately 90-120 min into each clamp). Blood pressure was monitored simultaneously during this period with a digital monitor (Takeda UA-751, A&D Company Ltd, Shibuya-ku, Tokyo, Japan).
Blood flow measurement
Limb blood flow was measured using venous occlusion plethysmography (Hokanson set, PMS Instruments, Hastings, Sussex, U.K.) [38] [39] [40] . Results were calibrated electronically using a MacLab analyser (AD Instruments, Castle Hill, Australia). A mercury strain-gauge of appropriate circumference (2 cm shorter than actual calf circumference) was placed around the calf 10 cm from the tibial tuberosity. An ankle cuff was inflated to 200 mmHg for 2 min before inflation of the venous cuff on the ipsilateral thigh. The venous occlusion pressure was 50 mmHg. Care was taken to ensure that the limb involved was relaxed. Five consecutive readings were taken over 3 min and thereafter the ankle cuff was deflated and rested for 3 min before the procedure was repeated. A total of 20 readings was taken at baseline and at each steady state. The mean inter-and intra-individual coefficients of variation of blood flow readings were 31.9 % and 13.1 % respectively.
Laboratory procedure
Plasma renin activity and aldosterone were measured by radioimmunoassays (Nichols Institute Diagnostics Ltd, Saffron Walden, Essex, U.K. and Diagnostic Products Corporation, Los Angeles, CA, U.S.A. respectively). Plasma angiotensin II levels were measured by radioimunoassay [41] . Plasma insulin was measured using an ELISA technique (DAKO Diagnostic Ltd, Ely, Cambs, U.K.) and glucose by the glucose oxidase method (Beckman Glucose Analyzer, Brea, CA, U.S.A.). Urinary free catecholamines were measured using reverse-phase HPLC and quantified by electrochemical detection [42] . 
Data analysis
RESULTS
Salt-loading resulted in a significant rise in urinary sodium excretion, body weight and suppression of plasma renin activity (Table 2) . Twenty-four-hour urinary noradrenaline was significantly suppressed by saltloading with no significant changes seen in adrenaline or dopamine. Plasma volume also showed a rising trend on salt-loading. There was a significant rise in daytime systolic blood pressure but no significant change was seen in either diastolic or mean arterial pressure (Table 3) . Pulse rate was not significantly different. Salt-loading ; insulin action and blood flow During hyperinsulinaemic-euglycaemic clamps, there were small but significant falls in diastolic pressures with both low-dose [δ l 2.3 (S.D.p6.2) mmHg, P l 0.03] and high-dose insulin [δ l 7.9 (S.D.p7.9) mmHg, P 0.001], regardless of salt intake. There were no significant changes in systolic blood pressure or heart rate during euglycaemic clamps.
Effects of salt intake on calf blood flow
There was no significant change in basal calf blood flow on salt-loading (Table 4) . Leg blood flow increased significantly at both low and high insulin doses for both levels of salt intake during hyperinsulinaemic clamp. The percentage increase in blood flow was significantly greater when subjects were on the high salt diet during high-dose insulin infusion (see Figure 2) .
Effects of salt intake on insulin sensitivity
Salt-loading had no effect on fasting plasma glucose or insulin levels at baseline or during high-and low-dose insulin infusion. Insulin sensitivity as measured by metabolic clearance rate and glucose infusion rate was similar at both insulin doses (see Table 4 ).
DISCUSSION
In healthy subjects, increasing plasma insulin concentration increases skeletal muscle blood flow [1, 8] and glucose extraction. This effect of insulin on muscle blood flow is dose-and time-dependent and the amount of glucose extraction is dependent on the degree of hyperinsulinamia. Laakso et al. [7] have demonstrated a marked increase in muscle blood flow using sequential insulin infusions over a period of 9-10 h with substantial increases in insulin-mediated glucose uptake. It has been shown that in insulin-resistant states, the effect of insulin on increasing skeletal muscle blood flow is attenuated [7, 9, [11] [12] [13] 43] . From such data Baron et al. hypothesized that insulin's effect on blood flow and the vascular tree in part determines insulin sensitivity. One test of this hypothesis is to change blood flow and observe whether there is an accompanying change in insulin action. Nuutila et al. [16] increased blood flow with bradykinin and found no effect on glucose clearance ; other groups have also found no relationship between blood flow and insulin-mediated glucose uptake using adenosine and angiotensin II infusions [17] [18] [19] . Our study sought to observe the effect of salt-loading and depletion on blood flow and glucose clearance.
Salt-loading has been extensively studied in healthy controls [27] [28] [29] 44, 45] and in certain disease states, e.g. hypertension [46, 47] . The conclusions of various studies differ depending on the population studied, but in general there is a consensus that salt-loading initially increases plasma volume and body weight. These in turn provoke compensatory mechanisms such as inhibition of the sympathetic nervous system [48] and RAA system. If these mechanisms do not achieve complete compensation, there may be increases in systolic, and to a lesser extent, diastolic blood pressure. Some individuals respond more to salt-loading than others. In our study, for both blood pressure and blood flow there were unimodal but positively skewed distributions of responses to salt.
Feldman et al. [26] found that salt restriction attenuated the vasodilating effect of insulin as assessed using the dorsal hand vein linear variable differential transformer technique ; insulin sensitivity, however, was not measured. Salt-loading has been shown to increase vasodilatation mediated by sodium nitroprusside but not by methacholine [25] . Salt-loading in our study was associated with changes in body weight, sympathetic tone and the RAA system. We found a significant suppression of 24-h urinary noradrenaline during salt-loading, consistent with other studies which found that salt-loading suppressed sympathetic activity resulting in a reduction of noradrenaline release [48, 49] . In our study, there were borderline significant changes in 24-h systolic blood pressure and plasma volume, and a significant increase in body weight and daytime systolic blood pressure. Basal limb blood flow, however, did not change on salt-loading in this study. It is not clear whether the lack of change in basal limb blood flow was due to the low precision of the plethysmography technique, causing a Type II error, or to the fact that compensatory mechanisms maintained blood flow independently of changes in blood pressure and plasma volume.
We tested the hypothesis that altering the salt content of the diet (and\or the compensatory effects it induces) would influence insulin action. We studied two actions of insulin : (1) whole-body glucose disposal and (2) vasodilatation.
Previous work has shown variable effects of saltloading on glucose metabolism\insulin resistance [30] [31] [32] [33] . For example, Grey et al. [32] did not find any change in insulin sensitivity after moderate salt-loading for 1 week in normal subjects although there was a significant rise in body weight. Donovan et al. [31] on the other hand, reported an increase in insulin sensitivity during severe salt restriction in eight normal males, with no significant changes in blood pressure and counterregulatory hormones, e.g. cortisol and dopamine. In our study there was no effect of salt intake on glucose metabolism.
In contrast, salt-loading caused an increase in insulininduced blood flow. In the salt-loaded state, blood flow increased by approximately 70 % when insulin was infused at 600 m-unit:min−":m−#, whereas in the saltdepleted state the equivalent blood flow increase was only 37.5 %. These results imply that salt-loading is capable of causing dissociation between the glucose clearance and vasodilatory effects of insulin. Our findings fail to support Baron's hypothesis [50] , that increase in blood flow is an important mechanism whereby insulin increases muscle glucose uptake, but are consistent with the findings of Nuutila et al. [16] , that insulin-mediated glucose uptake can be independent of blood flow. The latter found no significant increase in insulin-mediated glucose uptake despite increasing blood flow by 98 % using bradykinin.
Salt-loading and hyperinsulinaemia appear to have a synergistic effect on increasing blood flow in our study ; conversely, it has been shown that salt restriction attenuates insulin-mediated vasodilatation [26] . Salt on its own did not change blood flow significantly. One possible explanation could be that salt balance was achieved over the course of 5 days of salt-loading at the expense of increased plasma volume, increased systolic blood pressure, reduced urinary noradrenaline and suppression of the RAA system. Cardiac output (although not measured in this study) probably also increased by 6-10 % [27, 51] . During hyperinsulinaemia, cardiac output increases [8, 14] and total peripheral resistance falls. In our clamps, diastolic blood pressure fell significantly without significant change in systolic blood pressure in both salt-loaded and salt-depleted states. The mechanism by which salt modulates blood flow in the presence of hyperinsulinaemia remains to be identified.
In conclusion, our study demonstrated that saltloading increased body weight, suppressed the RAA system and noradrenaline release, increased insulin's vasodilatory effects but had no effect on insulin-mediated glucose uptake. Salt-loading can dissociate insulin's vascular and glucoregulatory effects, contrary to the prediction of Baron's hypothesis.
